Kunal Bhatia, CEO and co-founder, & Vignesh Baskaran, CTO and cofounder have both spent more than a decade building AI ...

These technologies are likely used by you every day but you probably never hear their names. They resolve domains, encrypt ...

Compute efficiency is therefore becoming part of model architecture. It should not be treated only as a deployment issue that ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

With AI inference now driving enterprise workloads, organizations must rethink infrastructure for speed, efficiency, ...

Layer 3 appchains offer dedicated networks that settle to an existing Layer 2, giving them exclusive throughput instead of ...

Tenstorrent launched JapanFold on September 3, 2026, a drug discovery platform serving open-source structural biology models ...

Compare 12 Ray-Ban Meta alternatives for AI, privacy, sports and displays, including their key features, prices and trade-offs, to find the right pair. If you can only read one tech story a day, this ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Today, Microsoft published its 2026 Responsible AI Transparency Report. The report highlights the progress we’ve made in building and deploying AI responsibly, supporting our customers, and ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

View the basic RXRX option chain and compare options of Recursion Pharmaceuticals, Inc. on Yahoo Finance.